Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Dermatological Drugs - GCC

GCC
  • The Dermatological Drugs market in the GCC is anticipated to witness a significant upsurge in revenue, with projections indicating a rise to US$178.40m by the year 2024.
  • This growth is expected to continue steadily, with an estimated annual growth rate (CAGR 2024-2029) of 5.71%.
  • As a result, the market volume is projected to reach US$235.40m by 2029.
  • In terms of global comparison, United States is expected to generate the highest revenue in the Dermatological Drugs market, reaching a staggering US$11.67bn in 2024.
  • The demand for dermatological drugs in the GCC is driven by the high prevalence of skin conditions and the increasing awareness of their treatment options.

Definition:
The Dermatological Drugs market covers treatments of diseases related to skin, nails, hair, and genital membranes. Typical examples are medications for eczema, acne, and rosacea. These preparations include ointments, creams, gels, pills, capsules, washing lotions, peelings, pastes, solutions, and sprays. Products which are primarily used for cosmetic purposes are not included.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Johnson & Johnson, Bayer, Leo Pharma, Galderma

In-Scope

  • Drugs to treat diseases related to skin, nails, hair, and genital membranes
  • Steroids such as corticosteroids (topical and systemic)
  • Topical antihistamines
  • Antifungals

Out-Of-Scope

  • Cosmetic products
  • Immunosuppressants to treat psoriasis
  • Skin cancer treatment
Dermatological Drugs: market data & analysis - Cover

Market Insights report

Dermatological Drugs: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    The demand for dermatological drugs in the GCC region has been steadily increasing in recent years.

    Customer preferences:
    One of the major factors driving the growth of the dermatological drugs market in GCC is the rising awareness and concern for skin health among the population. The hot and humid climate in the region, combined with the high prevalence of skin diseases, has led to a growing demand for effective dermatological treatments. Additionally, the increasing disposable income and changing lifestyle patterns have also contributed to the growth of this market.

    Trends in the market:
    The dermatological drugs market in GCC is witnessing several trends that are shaping its growth trajectory. One of the key trends is the increasing adoption of biologics and targeted therapies for the treatment of skin diseases. Biologics offer a more targeted approach to treating skin diseases, with fewer side effects than traditional treatments. Another trend is the growing popularity of over-the-counter (OTC) dermatological drugs, which are easily accessible and affordable.

    Local special circumstances:
    The GCC region has a unique set of circumstances that are driving the growth of the dermatological drugs market. The high prevalence of skin diseases in the region, such as psoriasis and eczema, is a major factor. Additionally, the hot and humid climate in the region can exacerbate skin conditions, leading to a higher demand for effective treatments. The growing number of medical tourists in the region is also contributing to the growth of the dermatological drugs market.

    Underlying macroeconomic factors:
    Several macroeconomic factors are driving the growth of the dermatological drugs market in GCC. The region has a high GDP per capita and a rapidly growing population, which is increasing demand for healthcare services. Additionally, the GCC governments are investing heavily in healthcare infrastructure and research and development, which is creating a favorable environment for the growth of the dermatological drugs market. The expanding private healthcare sector in the region is also contributing to the growth of this market.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Dermatological Drugs: market data & analysis - BackgroundDermatological Drugs: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.